Daniela Barone

Dr. Daniela Barone

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Campania, Italy
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in The Clinical Journal of Pain
Verified
Journal Article
Closed access
PDF file
Paola IndovinaPaola Indovina
Paola Indovina
DBDaniela Barone
Daniela Barone
Luigi GalloLuigi Gallo
Luigi Gallo
ACAndrea Chirico
Andrea Chirico
GPGiuseppe De Pietro
Giuseppe De Pietro
Antonio GiordanoAntonio Giordano
Antonio Giordano
Objectives: This review aims to provide a framework for evaluating the utility of virtual reality (VR) as a distraction intervention to alleviate pain and distress during medical procedures. We first describe the theoretical bases underlying the VR analgesic and anxiolytic effects and define the main factors contributing to its efficacy, which largely emerged from studies on healthy volunteers. Then, we provide a comprehensive overview of the clinical trials using VR distraction during different medical procedures, such as burn injury treatments, chemotherapy, surgery, dental treatment, and other diagnostic and therapeutic procedures. Methods: A broad literature search was performed using as main terms “virtual reality,” “distraction,” and “pain.” No date limit was applied and all the retrieved studies on immersive VR distraction during medical procedures were selected. Results: VR has proven to be effective in reducing procedural pain, as almost invariably observed even in patients subjected to extremely painful procedures, such as patients with burn injuries undergoing wound care, and physical therapy. Moreover, VR seemed to decrease cancer-related symptoms in different settings, including during chemotherapy. Only mild and infrequent side effects were observed. Discussion: Despite these promising results, future long-term randomized controlled trials with larger sample sizes and evaluating not only self-report measures but also physiological variables are needed. Further studies are also required both to establish predictive factors to select patients who can benefit from VR distraction and to design hardware/software systems tailored to the specific needs of different patients and able to provide the greatest distraction at the lowest cost.

1 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
ISIvana Sirangelo
Ivana Sirangelo
LSLUIGI SAPIO
LUIGI SAPIO
ARAngela Ragone
Angela Ragone
SNSilvio Naviglio
Silvio Naviglio
CIClara Iannuzzi
Clara Iannuzzi
MBMargherita Borriello
Margherita Borriello
Doxorubicin (doxo) is an effective anticancer compound in several tumor types. However, as a consequence of oxidative stress induction and ROS overproduction, its high cardiotoxicity demands urgent attention. Vanillin possesses antioxidant, antiproliferative, antidepressant and anti-glycating properties. Therefore, we investigated the potential vanillin protective effects against doxo-induced cardiotoxicity in H9c2 cells. Using multiparametric approach, we demonstrated that vanillin restored both cell viability and damage in response to doxo exposure. Contextually, vanillin decreased sub-G1 appearance and caspase-3 and PARP1 activation, reducing the doxo-related apoptosis induction. From a mechanistic point of view, vanillin hindered doxo-induced ROS accumulation and impaired the ERK phosphorylation. Notably, besides the cardioprotective effects, vanillin did not counteract the doxo effectiveness in osteosarcoma cells. Taken together, our results suggest that vanillin ameliorates doxo-induced toxicity in H9c2 cells, opening new avenues for developing alternative therapeutic approaches to prevent the anthracycline-related cardiotoxicity and to improve the long-term outcome of antineoplastic treatment.

28 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
AMAntonio Melillo
Antonio Melillo
ACAndrea Chirico
Andrea Chirico
Giuseppe De PietroGiuseppe De Pietro
Giuseppe De Pietro
Luigi GalloLuigi Gallo
Luigi Gallo
Giuseppe CaggianeseGiuseppe Caggianese
Giuseppe Caggianese
Antonio GiordanoAntonio Giordano
Antonio Giordano
Rehabilitation plays a crucial role in cancer care, as the functioning of cancer survivors is frequently compromised by impairments that can result from the disease itself but also from the long-term sequelae of the treatment. Nevertheless, the current literature shows that only a minority of patients receive physical and/or cognitive rehabilitation. This lack of rehabilitative care is a consequence of many factors, one of which includes the transportation issues linked to disability that limit the patient’s access to rehabilitation facilities. The recent COVID-19 pandemic has further shown the benefits of improving telemedicine and home-based rehabilitative interventions to facilitate the delivery of rehabilitation programs when attendance at healthcare facilities is an obstacle. In recent years, researchers have been investigating the benefits of the application of virtual reality to rehabilitation. Virtual reality is shown to improve adherence and training intensity through gamification, allow the replication of real-life scenarios, and stimulate patients in a multimodal manner. In our present work, we offer an overview of the present literature on virtual reality-implemented cancer rehabilitation. The existence of wide margins for technological development allows us to expect further improvements, but more randomized controlled trials are needed to confirm the hypothesis that VRR may improve adherence rates and facilitate telerehabilitation.

12 June 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
DBDaniela Barone
Daniela Barone
LCLetizia Cito
Letizia Cito
GTGiuseppina Tommonaro
Giuseppina Tommonaro
AAAgnese Anna Abate
Agnese Anna Abate
DPDanila Penon
Danila Penon
Antonio GiordanoAntonio Giordano
Antonio Giordano

2 January 2017 in Cell Cycle
Verified
Journal Article
Open access
EGE. Di Giacomo
E. Di Giacomo
EBE. Benedetti
E. Benedetti
LCL. Cristiano
L. Cristiano
AAAndrea Antonosante
Andrea Antonosante
Michele D'AngeloMichele D'Angelo
Michele D'Angelo
ACAnnamaria Cimini
Annamaria Cimini
PPARs are a class of ligand-activated transcription factors belonging to the superfamily of receptors for steroid and thyroid hormones, retinoids and vitamin D that control the expression of a large number of genes involved in lipid and carbohydrate metabolism and in the regulation of cell proliferation, differentiation and death. The role of PPARs in the CNS has been primarily associated with lipid and glucose metabolism; however, these receptors are also implicated in neural cell differentiation and death, as well as neuronal maturation. Although it has been demonstrated that PPARs play important roles in determining NSCs fate, less is known about their function in regulating NSCs metabolism during differentiation. In order to identify the metabolic events, controlled by PPARs, occurring during neuronal precursor differentiation, the glucose and lipid metabolism was followed in a recognized model of neuronal differentiation in vitro, the SH-SY5Y neuroblastoma cell line. Moreover, PPARs distribution were also followed in situ in adult mouse brains. The concept of adult neurogenesis becomes relevant especially in view of those disorders in which a loss of neurons is described, such as Alzheimer disease, Parkinson disease, brain injuries and other neurological disorders. Elucidating the crucial steps in energetic metabolism and the involvement of PPARγ in NSC neuronal fate (lineage) may be useful for the future design of preventive and/or therapeutic interventions.

2 April 2018 in Oncogene
Verified
Journal Article
Closed access
PDF file
Francesca PentimalliFrancesca Pentimalli
Francesca Pentimalli
IFIris Maria Forte
Iris Maria Forte
LELuca Esposito
Luca Esposito
Paola IndovinaPaola Indovina
Paola Indovina
ACAntonella Iannuzzi Carmelina
Antonella Iannuzzi Carmelina
Antonio GiordanoAntonio Giordano
Antonio Giordano